FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
41.4 EUR
+0.86 (+2.12%)
FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. FME has only an average score on both its financial health and profitability. FME is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year FME was profitable.
FME had a positive operating cash flow in the past year.
FME had positive earnings in each of the past 5 years.
Each year in the past 5 years FME had a positive operating cash flow.
1.2 Ratios
FME has a Return On Assets (2.10%) which is in line with its industry peers.
FME has a Return On Equity of 4.95%. This is in the lower half of the industry: FME underperforms 62.96% of its industry peers.
With a Return On Invested Capital value of 3.84%, FME perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 6.90%.
The last Return On Invested Capital (3.84%) for FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROIC | 3.84% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
FME has a Profit Margin (3.36%) which is comparable to the rest of the industry.
FME's Profit Margin has declined in the last couple of years.
FME has a Operating Margin (7.15%) which is in line with its industry peers.
In the last couple of years the Operating Margin of FME has declined.
FME's Gross Margin of 24.67% is in line compared to the rest of the industry. FME outperforms 55.56% of its industry peers.
FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FME is destroying value.
The number of shares outstanding for FME remains at a similar level compared to 1 year ago.
Compared to 5 years ago, FME has less shares outstanding
FME has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.16 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
FME has a Altman-Z score of 2.16. This is comparable to the rest of the industry: FME outperforms 59.26% of its industry peers.
The Debt to FCF ratio of FME is 5.47, which is a neutral value as it means it would take FME, 5.47 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of FME (5.47) is better than 74.07% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that FME is somewhat dependend on debt financing.
The Debt to Equity ratio of FME (0.71) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Altman-Z | 2.16 |
ROIC/WACC0.68
WACC5.65%
2.3 Liquidity
A Current Ratio of 1.44 indicates that FME should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.44, FME is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that FME should not have too much problems paying its short term obligations.
FME's Quick ratio of 1.08 is fine compared to the rest of the industry. FME outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.43% yearly.
FME shows a decrease in Revenue. In the last year, the revenue decreased by -0.61%.
FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.70% yearly.
FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.96% yearly.
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.01, which indicates a very decent valuation of FME.
FME's Price/Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 92.59% of the companies in the same industry.
FME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.47.
With a Price/Forward Earnings ratio of 9.99, the valuation of FME can be described as very reasonable.
Based on the Price/Forward Earnings ratio, FME is valued cheaper than 85.19% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of FME to the average of the S&P500 Index (34.42), we can say FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.01 | ||
| Fwd PE | 9.99 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FME.
Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.06 | ||
| EV/EBITDA | 10.68 |
4.3 Compensation for Growth
FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FME's earnings are expected to grow with 13.44% in the coming years.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y12.9%
EPS Next 3Y13.44%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.63%, FME has a reasonable but not impressive dividend return.
FME's Dividend Yield is rather good when compared to the industry average which is at 2.09. FME pays more dividend than 100.00% of the companies in the same industry.
FME's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.63% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
FME pays out 64.37% of its income as dividend. This is not a sustainable payout ratio.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP64.37%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
FRA:FME (11/24/2025, 5:36:15 PM)
41.4
+0.86 (+2.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.29B
Revenue(TTM)19.34B
Net Income(TTM)656.42M
Analysts65.6
Price Target48.43 (16.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.63% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP64.37%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.03%
Min EPS beat(2)14.89%
Max EPS beat(2)27.17%
EPS beat(4)4
Avg EPS beat(4)20.72%
Min EPS beat(4)14.89%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)15.78%
EPS beat(12)10
Avg EPS beat(12)13.92%
EPS beat(16)12
Avg EPS beat(16)10.11%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)2.74%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-3.8%
PT rev (3m)-4.91%
EPS NQ rev (1m)8.29%
EPS NQ rev (3m)6.47%
EPS NY rev (1m)0.52%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.01 | ||
| Fwd PE | 9.99 | ||
| P/S | 1.24 | ||
| P/FCF | 12.06 | ||
| P/OCF | 8.82 | ||
| P/B | 1.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.68 |
EPS(TTM)3.76
EY9.08%
EPS(NY)4.14
Fwd EY10.01%
FCF(TTM)3.43
FCFY8.29%
OCF(TTM)4.69
OCFY11.34%
SpS33.26
BVpS22.61
TBVpS-2.73
PEG (NY)0.6
PEG (5Y)N/A
Graham Number43.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROCE | 5.44% | ||
| ROIC | 3.84% | ||
| ROICexc | 4.19% | ||
| ROICexgc | 11.45% | ||
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% | ||
| FCFM | 10.32% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Debt/EBITDA | 3.14 | ||
| Cap/Depr | 45.83% | ||
| Cap/Sales | 3.79% | ||
| Interest Coverage | 3.82 | ||
| Cash Conversion | 91.56% | ||
| Profit Quality | 307% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.16 |
F-Score6
WACC5.65%
ROIC/WACC0.68
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
EBIT growth 1Y2.71%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y19.09%
FCF growth 1Y14.07%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y14.41%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 11.01 and the Price/Book (PB) ratio is 1.83.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 6 / 10 and the dividend payout ratio is 64.37%.